Similar articles for PMID: 28102361

Year	Number of Results
1997	1
1998	1
1999	1
2000	3
2002	1
2003	2
2005	4
2006	2
2007	3
2008	1
2009	3
2010	2
2011	1
2012	7
2013	6
2014	2
2015	3
2016	3
2017	6
2018	3
2020	1
2021	1
2024	0

1

Effectiveness and Tolerability of Different Recommended Doses of PPIs and H₂RAs in GERD: Network Meta-Analysis and GRADE system.

Zhang C, Kwong JS, Yuan RX, Chen H, Xu C, Wang YP, Yang GL, Yan JZ, Peng L, Zeng XT, Weng H, Luo J, Niu YM. Zhang C, et al. Sci Rep. 2017 Jan 19;7:41021. doi: 10.1038/srep41021. Sci Rep. 2017. PMID: 28102361 Free PMC article.

2

Short-term treatment of gastroesophageal reflux disease.

van Pinxteren B, Numans ME, Lau J, de Wit NJ, Hungin AP, Bonis PA. van Pinxteren B, et al. J Gen Intern Med. 2003 Sep;18(9):755-63. doi: 10.1046/j.1525-1497.2003.20833.x. J Gen Intern Med. 2003. PMID: 12950485 Free PMC article. Review.

3

Comparative effectiveness of histamine-2 receptor antagonists as short-term therapy for gastro-esophageal reflux disease: a network meta-analysis.

Zhao F, Wang S, Liu L, Wang Y. Zhao F, et al. Int J Clin Pharmacol Ther. 2016 Oct;54(10):761-70. doi: 10.5414/CP202564. Int J Clin Pharmacol Ther. 2016. PMID: 27443665 Review.

4

Vonoprazan versus proton pump inhibitors for the management of gastroesophageal reflux disease: A protocol for a systematic review with meta-analysis.

Kang H, Kim BJ, Choi G, Kim JG. Kang H, et al. Medicine (Baltimore). 2018 Sep;97(39):e12574. doi: 10.1097/MD.0000000000012574. Medicine (Baltimore). 2018. PMID: 30278564 Free PMC article.

5

Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.

Higginbotham TW. Higginbotham TW. Ann Pharmacother. 2010 Mar;44(3):572-6. doi: 10.1345/aph.1M519. Epub 2010 Feb 2. Ann Pharmacother. 2010. PMID: 20124466 Review.

6

Efficacy and safety of histamine-2 receptor antagonists.

van der Pol R, Langendam M, Benninga M, van Wijk M, Tabbers M. van der Pol R, et al. JAMA Pediatr. 2014 Oct;168(10):947-54. doi: 10.1001/jamapediatrics.2014.1273. JAMA Pediatr. 2014. PMID: 25133940 Review.

7

Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.

Houben E, Johansson S, Nagy P, Penning-van Beest FJA, Kuipers EJ, Herings RMC. Houben E, et al. Curr Med Res Opin. 2018 Apr;34(4):577-583. doi: 10.1080/03007995.2017.1407302. Epub 2017 Nov 24. Curr Med Res Opin. 2018. PMID: 29149805

8

Drugs, bugs, and esophageal pH profiles.

Robinson M. Robinson M. Yale J Biol Med. 1999 Mar-Jun;72(2-3):169-72. Yale J Biol Med. 1999. PMID: 10780578 Free PMC article. Review.

9

New therapeutic options in the treatment of GERD and other acid-peptic disorders. Based on a presentation by Duane D. Webb, MD, FACG.

[No authors listed] [No authors listed] Am J Manag Care. 2000 May;6(9 Suppl):S467-75. Am J Manag Care. 2000. PMID: 10977486 Free article. Review.

10

Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.

Tonini M, Vigneri S, Neri M, Cuomo R, Savarino V, Pace F. Tonini M, et al. Digestion. 2007;76(3-4):171-8. doi: 10.1159/000111985. Epub 2007 Nov 28. Digestion. 2007. PMID: 18046084 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

49 results

Results by year